FAM126B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.467200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.321200E-01
Normal-vs-Stage2
8.928200E-01
Normal-vs-Stage3
3.830000E-01
Normal-vs-Stage4
7.730000E-01
Stage1-vs-Stage2
9.183400E-01
Stage1-vs-Stage3
1.395210E-01
Stage1-vs-Stage4
4.287200E-01
Stage2-vs-Stage3
2.757000E-01
Stage2-vs-Stage4
5.214200E-01
Stage3-vs-Stage4
1.406150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.325600E-01
Normal-vs-AfricanAmerican
9.258000E-01
Normal-vs-Asian
7.966000E-01
Caucasian-vs-AfricanAmerican
9.123600E-01
Caucasian-vs-Asian
9.170800E-01
AfricanAmerican-vs-Asian
8.690600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.918200E-01
Normal-vs-Female
9.087600E-01
Male-vs-Female
6.574800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.657400E-01
Normal-vs-Age(41-60Yrs)
7.928800E-01
Normal-vs-Age(61-80Yrs)
7.272000E-01
Normal-vs-Age(81-100Yrs)
4.432400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.923200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.185200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.595400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.007900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.808100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.563800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.512400E-01
Normal-vs-Daily Drinker
5.554600E-01
Normal-vs-Weekly Drinker
9.112400E-01
Normal-vs-Occasional Drinker
6.992200E-01
Normal-vs-Social Drinker
8.716400E-01
Non Drinker-vs-Daily Drinker
6.780400E-01
Non Drinker-vs-Weekly Drinker
4.965800E-01
Non Drinker-vs-Occasional Drinker
7.414500E-02
Non Drinker-vs-Social Drinker
6.368000E-01
Daily Drinker-vs-Weekly Drinker
3.982800E-01
Daily Drinker-vs-Occasional Drinker
4.802300E-02
Daily Drinker-vs-Social Drinker
4.543200E-01
Weekly Drinker-vs-Occasional Drinker
8.936000E-01
Weekly Drinker-vs-Social Drinker
6.808000E-01
Occasional Drinker-vs-Social Drinker
3.170200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.542400E-02
Normal-vs-Grade 2
1.234450E-02
Normal-vs-Grade 3
8.943000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.248400E-02
Grade 1-vs-Grade 3
1.877930E-02
Grade 1-vs-Grade 4
3.542400E-02
Grade 2-vs-Grade 3
6.355400E-01
Grade 2-vs-Grade 4
1.234450E-02
Grade 3-vs-Grade 4
8.943000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.431200E-01
Normal-vs-NonDiabetic
8.258600E-01
Diabetic-vs-NonDiabetic
4.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.787600E-01
Normal-vs-NoPancreatitis
8.078800E-01
Pancreatitis-vs-NoPancreatitis
7.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.743000E-01
Normal-vs-N1
9.264600E-01
N0-vs-N1
3.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.818000E-01
Normal-vs-TP53-NonMutant
9.111800E-01
TP53-Mutant-vs-TP53-NonMutant
1.822370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
